v3.25.4
Stock-based Payment Arrangements
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based Payment Arrangements Stock-based Payment Arrangements
The Company’s shareholders approved the 2009 Stock Option Plan (the “SOP”) and the 2009 Recognition and Retention Plan (the “RRP”) on May 12, 2009 to provide incentives and awards for directors, officers, and other key employees of the Company and its subsidiary. A maximum of 892,687 shares of Company common stock were reserved for issuance upon the exercise of options granted under the SOP. A total of 357,075 shares of the Company’s outstanding common stock, or 4% of total shares outstanding at the time the RRP was implemented, were approved for restricted stock awards under the RRP. The SOP and RRP expired February 2019. Expiration of the SOP and RRP did not affect any unvested options or awards granted. On May 6, 2014, the Company’s shareholders approved the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan authorizes the granting of stock options, restricted stock units and other awards to directors, officers and other key employees. An aggregate of 350,000 shares of our common stock was reserved for issuance pursuant to awards under the 2014 Plan. The 2014 Plan expired on May 6, 2024. On May 5, 2021, the Company’s shareholders approved the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan authorizes the granting of stock options, restricted stock units and other awards to directors, officers and other key employees. An aggregate of 435,000 shares of our common stock was reserved for issuance pursuant to awards under the 2021 Plan. These plans are administered by a committee appointed by the Board of Directors, which selects persons eligible to receive awards and determines the number of shares and/or options subject to each award, the terms, conditions and other provisions of the awards. In accordance with ASC 718, the Company adopted a fair value based method of accounting for employee stock compensation plans, whereby compensation cost is measured as of the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period.
Stock Option Plans
The Company has issued stock options under the SOP and the 2014 Plan to directors, officers and other key employees. The option exercise price cannot be less than the fair value of the underlying common stock as of the date of the option grant and the maximum option term cannot exceed ten years. All stock options granted have been issued with vesting periods of five years with accelerated vesting provided under certain circumstances. As of December 31, 2025, options to acquire an aggregate of 76,186 shares were outstanding under the SOP and the 2014 Plan. The Company has not granted stock options to directors, officers and other key employees since 2022 under the approved equity incentive plans.
As of December 31, 2025, there was $34,000 of unrecognized compensation cost related to stock options which is expected to be recognized over a period of 0.6 years.
For the years ended December 31, 2025, 2024 and 2023, the Company recognized $77,000, $104,000 and $144,000, respectively, in compensation cost related to stock options, which is included in compensation and benefits expense in the accompanying consolidated statements of income.
The following table represents stock option activity for the years indicated.
OptionsNumber of OptionsWeighted-Average Exercise PriceWeighted-Average Grant Date Fair ValueWeighted-Average Remaining Contractual Term (Years)
Outstanding as of December 31, 2022181,383 $32.64 $6.95 
Granted— — — 
Exercised(20,816)26.31 5.58 
Forfeited(3,880)34.33 7.61 
Outstanding as of December 31, 2023156,687 $33.34 $7.09 4.9
Granted— — — 
Exercised(37,820)31.85 6.48 
Forfeited(900)44.14 10.16 
Outstanding as of December 31, 2024117,967 $33.85 $7.29 4.1
Granted— — — 
Exercised(34,274)31.78 6.55 
Forfeited(7,507)30.28 6.49 
Outstanding as of December 31, 202576,186 $35.14 $7.70 3.7
Exercisable as of December 31, 2023117,870 $33.54 $6.97 4.3
Exercisable as of December 31, 202497,504 $33.90 $7.11 3.7
Exercisable as of December 31, 202568,237 $34.84 $7.43 3.4
Restricted Stock Plans
The Company has issued restricted stock under the RRP to directors, officers and other key employees. During 2009, the Company purchased in the open market all shares required to fund the RRP at an average cost of $11.81 per share. As of December 31, 2025, no shares were outstanding under the RRP Plan.
Awards under the RRP, 2014 and the 2021 Plan may not be sold or otherwise transferred until certain restrictions have lapsed. The unearned compensation related to these awards is amortized to compensation expense over the 5-year vesting period. The total share-based compensation expense for these awards is determined based on the market price of the Company’s common stock as of the date of grant applied to the total number of shares granted and is amortized over the vesting period. As of December 31, 2025, unearned share-based compensation associated with these awards totaled $3,741,000 with a weighted average remaining life of 3.1 years.
For the years ended December 31, 2025, 2024 and 2023, the Company recognized $1,320,000, $1,017,000 and $762,000, respectively, in compensation cost related to restricted stock and restricted stock units, which is included in compensation and benefits expense in the accompanying consolidated statements of income.
The following table represents unvested restricted stock activity for the years indicated.
Restricted StockNumber of
Shares		Weighted-Average Grant Date Fair Value
Balance, December 31, 202274,062 $34.58 
Granted45,065 30.37 
Forfeited(6,375)32.88 
Released(19,814)35.04 
Balance, December 31, 202392,938 $32.55 
Granted46,800 37.52 
Forfeited(340)32.06 
Released(25,156)32.66 
Balance, December 31, 2024114,242 $34.56 
Granted35,795 51.32 
Forfeited— — 
Released(34,160)34.05 
Balance, December 31, 2025115,877 $39.89